Home | Search | Contact Us | Volunteer Login | Franšais

stay connected

Would you like to get great articles on disease management, inspiring volunteer and patient stories, and the newly-designed online edition of The Journal delivered to your inbox? Subscribe to CCFC’s electronic newsletter ‘Talk About GUTS!’

 

 

IBD Watch

Free registration may be required to access some articles. From time to time, websites and blogs and other publications make claims that CCFC endorses a treatment or product as a “cure” for inflammatory bowel disease (IBD). Any significant news and announcements involving CCFC and IBD research advances will be posted here, on our own website. If you have any questions or concerns about the credibility of any claims you see related to CCFC or IBD treatment or research advances, please contact us at ccfc@ccfc.ca.

  • Wait times for gastroenterology care are getting longer News Release
  • An international research team led by a geneticist at Mount Sinai has found the reason why Ashkenazi Jews are four times more likely to be affected by Crohn’s disease than any other group. Article
  • Health Council of Canada releases report on self-management support for Canadians with chronic health conditions.  Click here to read the full report.
  • Canadian Institute for Health Information launches new online hospital rating tool. The Canadian Hospital Reporting Project (CHRP) is a national quality improvement initiative from the Canadian Institute for Health Information (CIHI). CHRP's web-based, interactive tool gives hospital decision-makers, policy-makers and Canadians access to indicator results for more than 600 facilities from every province and territory in Canada.
  • The "How To" Health Guide, developed by the Health Charities Coalition of Canada (HCCC), assists patients, caregivers, friends and families in managing information about the Canadian health care system, which can often be challenging to navigate. As a member of HCCC, CCFC played a role in the deveopment of this publication.
  • CCFC funded study discovers pathway that may contribute to the symptoms related to IBD. News Release
  • Toronto Star article says Canada tops the list of countries for IBD. Article
  • Health Canada approval expands Remicade Crohn’s disease indication to include reduction in steroid use and mucosal healing. Press Release
  • The Ontario government recently introduced a bill providing family caregivers the same personal leave rights as those with a personal emergency or who are donating an organ. It entitles an employee up to 8 weeks of leave without pay to care for a family member, if a qualified health practitioner issues a certificate stating that individual has a serious medical condition. View the bill @ http://bit.ly/uK5lSo
  • How do Sicker Canadians with Chronic Disease Rate the Health Care System? Read Health Council of Canada's complete report and watch patient video.
  • Low levels of vitamin D linked to IBD Article 
  • Canadian gastroenterologists' use and perceptions of infliximab in the treatment of refractory IBD More
  • CCFC-funded study finds high levels of bacteria in cancerous bowel tumours but the link is unclear. More
  • Hypothesis: What made Canada become a country with the highest incidence of IBD: Could sucralose be the culprit? More
  • Health care resource use and costs in Crohn's disease before and after infliximab therapy. Abstract
  • Study-level results were pooled from all clinical trials of adalimumab for moderate to severe CD in which work productivity outcomes were evaluated. Work Productivity and Activity Impairment Questionnaire outcomes (absenteeism, presenteeism and total work productivity impairment [TWPI]) were extracted from adalimumab trials. Abstract
  • Effective immediately Humira is now eligible for Ontario Public Drug Program reimbursement for fistulizing Crohn's disease with concomitant luminal disease through the Exceptional Access Program. For specific indication information, please click here
  • Health Canada approves Remicade (infliximab) for use in pediatric patients (age six to 17 years) with ulcerative colitis. More
  • CCFC-funded study uncovers gene associated with ulcerative colitis and - more exciting - the role this gene - RAC1 - plays in causing colitis. News Release
  • Canadian Digestive Health Foundation's free app, Gi Bodyguard, helps IBD patients track and share information with physicians.  More 
  • Toronto's SickKids creates myIBD, a free app to monitor Crohn's and colitis Article | Sick Kids IBD Academy
  • Gene Expression and Infliximab Treatment in Ulcerative Colitis  Article
  • Non-Steroidal Anti-Inflammatory Drugs and Colorectal Cancer Risk  More Article
  • CCFC funded researchers pinpoint role of key proteins in Crohn's Disease Article 
  • CCFC-funded study shows the anxiety may be in your gut, not your head! Article
  • Gastrostomy tube insertion in children: The Edmonton experience Article
  • CCFC-funded, McMaster researcher finds link between gut bacteria and behaviour  Article
  • Long-Term Development of Bone Geometry and Muscle in Pediatric IBD Report 
  • Outcome Following Thiopurine Use in Children With Ulcerative Colitis Report
  • Chiropractic treatment for gastrointestinal problems: A systematic review of clinical trials Abstract
  • Predicting, treating and preventing postoperative recurrence of Crohn's disease: The state of the field Abstract
  • Research links 29 genome regions with common form of inflammatory bowel disease News Release
  • Ethnic variation in the annual rates of adult inflammatory bowel disease in hospitalized patients in Vancouver, British Columbia  Abstract
  • Low-income children with IBD are more likely to undergo surgery than their wealthier counterparts News Release
    Canadian Association of Gastroenterology position statement on screening indiviudals at average risk for developing colorectal cancer. Article
  • How well does the Internet answer patients' questions about inflammatory bowel disease? Abstract
  • Comparing patient and endoscopist perceptions of the colonoscopy indication Abstract
  • Is there any rationale for the use of Ankaferd Blood Stopper in gastrointestinal bleeding? Article
  • Mycobacterium avium paratuberculosis and the etiology of Crohn's disease: A review of the controversy from the clinician's perspective Abstract
  • The impact of patient education on the quality of inpatient bowel preparation for colonoscopy Abstract